According to TriSalus Life Sciences's latest financial reports the company's current EPS (TTM) is -ยฃ1.05. In 2025 the company made an earnings per share (EPS) of -ยฃ1.37 a decrease over its 2024 EPS that were of -ยฃ0.99.